about
Insights into Chronic Wasting Disease and Bovine Spongiform Encephalopathy Species Barriers by Use of Real-Time ConversionIncreased susceptibility of transgenic mice expressing human PrP to experimental sheep bovine spongiform encephalopathy is not due to increased agent titre in sheep brain tissue.Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potentialMolecular modeling of prion transmission to humansVariant CJD. 18 years of research and surveillance.Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.Computational modeling of the relationship between amyloid and disease.Molecular barriers to zoonotic transmission of prions.The application of in vitro cell-free conversion systems to human prion diseases.Biochemical and strain properties of CJD prions: complexity versus simplicity.The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt-Jakob disease.Human prion diseases: molecular, cellular and population biology.Exploring the zoonotic potential of animal prion diseases: in vivo and in vitro approaches.Implications of peptide assemblies in amyloid diseases.Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner.Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humansScientific Opinion on a request for a review of a scientific publication concerning the zoonotic potential of ovine scrapie prionsSubstitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions
P2860
Q30376453-DCFAE727-B534-40BB-9D26-C0AF3F9D5613Q33918648-16B02C48-BC8F-4E77-85CA-CEC24CE0594DQ34249065-28BF14C8-8462-47E3-9263-8457479388E1Q34423397-1552C01A-DE2B-486B-B241-2AF995EC9ABEQ34453109-37297131-853E-4D00-BD48-1D09D3569EB5Q35036649-8CF0B964-5C56-49DB-A4E1-E57801E985AEQ35960528-77F7EA31-FEFB-441F-908E-A60C9EA63F5CQ36677013-8DC8FA72-B052-47A1-B19C-2870745B11B3Q37449082-C641597A-E903-447E-B1D1-6EBB01BB1DA6Q37763862-9E24B567-3035-4505-A270-13F39339D464Q37905853-A40B4EF4-C36C-4F4C-BB76-93569035D6C6Q37989099-E8BAE015-D90E-4624-B426-8724632D7A44Q38075119-544F3664-04CD-4CCF-A792-2C450BCAF8C5Q38189236-8B610A26-061F-48DF-9165-978F93588D17Q39431937-36BE9A49-AD9E-4D00-969E-4DD7DA2971B8Q40087612-786E90DF-1A3F-4C1E-AF2A-1E7D76512248Q46174770-B7B0A662-5397-41A7-993F-7C38FDEC23E5Q47149313-09A2E52C-D2BB-4D0E-B42C-4BA1C71B011AQ47157217-D9AE232A-D1D0-4899-8562-85256F8071B0Q48381755-E3142F0D-F16E-428A-8DC7-F435044A0467Q56559501-23E7C67D-8F6B-465C-B9A4-9567A6FE21FA
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Molecular model of prion transmission to humans.
@ast
Molecular model of prion transmission to humans.
@en
Molecular model of prion transmission to humans.
@nl
type
label
Molecular model of prion transmission to humans.
@ast
Molecular model of prion transmission to humans.
@en
Molecular model of prion transmission to humans.
@nl
prefLabel
Molecular model of prion transmission to humans.
@ast
Molecular model of prion transmission to humans.
@en
Molecular model of prion transmission to humans.
@nl
P2860
P50
P356
P1476
Molecular model of prion transmission to humans.
@en
P2093
Christopher Prowse
Martin Jeffrey
P2860
P304
P356
10.3201/EID1512.090194
P577
2009-12-01T00:00:00Z